Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Pal K; Department of Primary Care and Population Health, UCL, London, UK.; Sharma M
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology
-
Source:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2022 Aug; Vol. 31 (8), pp. 892-900. Date of Electronic Publication: 2022 Jun 10.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Carvalho-E-Silva AP; Musculoskeletal Health Research Group, Faculty of Medicine and Health, School of Health Sciences, The University of Sydney, Sydney, NSW, Australia.; Institute of Bone and Joint Research, The Kolling Institute, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology
-
Source:
European journal of pain (London, England) [Eur J Pain] 2021 Jul; Vol. 25 (6), pp. 1264-1273. Date of Electronic Publication: 2021 Mar 16.Publisher: Wiley Country of Publication: England NLM ID: 9801774 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Faillie JL; Department of Medical Pharmacology and Toxicology, CHU Montpellier University Hospital, Montpellier, France.; UA11 Institute Desbrest of Epidemiology and Public Health, INSERM, University of Montpellier, Montpellier, France.
Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*adverse effects ; Incretins/Incretins/Incretins/*adverse effects
-
Source:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Jan; Vol. 111 (1), pp. 272-282. Date of Electronic Publication: 2021 Oct 16.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Cea-Soriano L; Department of Public Health and Maternal and Child Health, Faculty of Medicine, Complutense University of Madrid, Madrid, Spain.; Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, Spain.
Subjects: Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*drug therapy ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glycated Hemoglobin/Glycated Hemoglobin/Glycated Hemoglobin/*analysis
-
Source:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2018 Aug; Vol. 27 (8), pp. 940-948. Date of Electronic Publication: 2018 May 08.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Saine ME; Center for Clinical Epidemiology and Biostatistics, Center for Pharmacoepidemiology Research and Training, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use ; Patient Admission/Patient Admission/Patient Admission/*statistics & numerical data
-
Source:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2019 Oct; Vol. 28 (10), pp. 1328-1335. Date of Electronic Publication: 2019 Jul 22.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Karp I; Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.; Département de médecine sociale et préventive, Université de Montréal, Montréal, Québec, Canada.
Subjects: Carcinogenesis/Carcinogenesis/Carcinogenesis/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*adverse effects
-
Source:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2019 Apr; Vol. 28 (4), pp. 489-499. Date of Electronic Publication: 2019 Feb 18.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Elder DH; Division of Cardiovascular and Diabetes Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.; Singh JS
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy
-
Source:
European journal of heart failure [Eur J Heart Fail] 2016 Jan; Vol. 18 (1), pp. 94-102. Date of Electronic Publication: 2015 Dec 13.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:
Record details
